Mercor is conducting a paid research study in collaboration with a leading AI research lab focused on improving healthcare. We are seeking board-certified urologists and medical oncologists in the United States who manage patients with metastatic prostate cancer to take part in a short online survey about treatment decision-making.
Responsibilities
Participants will be asked to:
- Complete a structured ~30-minute online survey
- Share perspectives on how you evaluate and select systemic treatments for patients with prostate cancer
- Submit all responses within the given timeline
Requirements
- Urologist or medical oncologist with an MD or DO
- Board certified in your specialty
- Hold an active, unrestricted US medical license and practice primarily in the United States
- Spend at least 25% of your professional time in direct patient care
- Have cared for prostate-cancer patients in the past 12 months, including at least one patient with metastatic hormone-sensitive (mHSPC) or castration-resistant (mCRPC) prostate cancer
- Regularly manage metastatic prostate cancer, with primary or shared responsibility for selecting systemic treatment
- Able to independently complete a ~30-minute online survey
Please note: this study is not open to anyone who has taken part in prostate-cancer market research in the past 3 months, or who (or whose immediate family) works for a pharmaceutical, diagnostics, market research, or advertising company, a wholesaler, or a specialty pharmacy.
Engagement Details
- Format: Online survey
- Duration: Approximately 30 minutes
- Compensation: One-time payment upon successful verification of the submission
- Location: Remote (United States)
Why Participate
- Contribute to research shaping the next generation of healthcare AI tools
- Share your real-world clinical expertise in managing advanced prostate cancer